9352 Rene' Aarnink: Prostate tissue classification from texture description. Internet 1996. 8954 Richard J. Babaian: Prostate cancer - a diagnostic dilemma. Internet 1995. R. Badalament a.o.: Algorithm for predicting nonorgan confined prostate cancer using results obtained from sextant core biopsies with prostate specific antigen level. J. Urology October 1996, ... 20369 C. Bangma/S. Roemeling/F. Schröder: Overdiagnosis and overtreatment of early detected prostate cancer. World J. Urol. 25 (2007), 3-9. 11453 Marcia Barinaga: Study suggests new way to gauge prostate cancer risk. Science 23 January 1998, 475. Men whose blood contains high levels of IGF-I (insulin-like growth factor) are 4 times more likely to develop prostate cancer than men with low IGF-I levels. See 11454 Chan/. 18582 Luigi Benecchi: Neuro-fuzzy system for prostate cancer diagnosis. Urology 68/2 (2006), 357-361. 11454 June Chan a.o.: Plasma insulin-like growth factor-I and prostate cancer risk - a prospective study. Science 23 January 1998, 563-566. L. Coetzee/L. Layfield/V. Hars/D. Paulson: Proliferative index determination in prostatic carcinoma tissue: is there any additional prognostic value greater than that of gleason score, ploidy and pathological stage? J. Urology January 1997, ... H. Dayal/C. Chui: Factors associated with racial differences in survival for prostatic carcinoma. J. Chronic Diseases 35 (1982), 553-560. 15594 Saravana Dhanasekaran a.o.: Delineation of prognostic biomarkers in prostate cancer. Nature 23 August 2001, 822-826. A. Elgamal a.o.: Impalpable invisible stage T1c prostate cancer - characteristics and clinical relevance in 100 radical prostatectomy specimens - different view. J. Urology January 1997, ... J. Epstein/J. Sauvageot: Do close but negative margins in radical prostatectomy specimens increase risk of postoperative progression? J. Urology January 1997, ... L. Eskew/R. Bare/D. McCullough: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of prostate. J. Urology January 1997, ... 15779 Ruth Etzioni/Charles Kooperberg/Margaret Pepe/Robert Smith: Combining biomarkers to detect disease with application to prostate cancer. Internet ca. 2003, 28p. 15475 Patrik Finne a.o.: Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examination. European Urology 41 (2002), 619-627. Marc Garnick: Prostate cancer. Screening, diagnosis, and management. Annals Internal Medicine 118/10 (1993), 804-818. B. Gburek a.o.: Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization. J. Urology January 1997, ... 9140 John Henkel: Prostate cancer. New tests create treatment dilemma. Internet, ca. 1995. 9020 John Hickner: Review of an article by S. Cantor a.o. on Prostate cancer screening in J. Fam. Pract. June 1995. Internet, ca. 1995. 10158 Inge Hoefer (ed.): Krebsmedizin. Spektrum Spezial 5 (1997). Michael Kattan a.o.: Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer ... (1997), 528-... Fernand Labrie: Prostate cancer - recent advances in diagnosis and treatment. Blackwell 1997. 1-89809911-1. $40. James Lewis/E. Roy Berger/James Lewis: New guidelines for diagnosing and treating prostate cancer. Health Education Literary Publisher 1997, 0-91525347-X. $23. 8993 Shutsung Liao: The development of hormone independent disease: Is there a chance for a cure? Internet 1995. 8860 Kristen Lidke Finn: Planting seeds of progress against prostate disease. Advance Summer 1995, 6-8, 10, 12-13. About John Oesterling. 19913 Lionel Lim/Kevin Sherin: Screening for prostate cancer in US men. ACPM position statement on preventive practice. Am. J. Prev. Med. 34/2 (2008), 164-170. Charles Mann: The prostate-cancer dilemma. Atlantic Monthly 272/5 (1993), 102-118. Sheldon Marks: Prostate & cancer. A family guide to diagnosis, treatment, and survival. Fisher Books. 9144 M. Melekos: Prognostic factors in prostate cancer. Cancer J. 9/4 (1996), ... M. Menon: Predicting Biological Aggressiveness in prostate cancer - desperately seeking marker. J. Urology January 1997, ... Sylvan Meyer/Seymour Nash: Prostate cancer. Making survival decisions. Chicago UP. 14461 Clara Migliavacca: Prostata - cosa fare prima che scoppi l'allarme. Fondamentale Giugno 2001, 26-31. 19969 Onisuru Okotie/.../William Catalona: Characteristics of prostate cancer detected by digital rectal examination only. Urology 70/6 (2007), 1117-1120. D. Ornstein a.o.: Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels. J. Urology January 1997, ... Melanie Osl/.../Klaus Weinberger/.../Christian Baumgartner: A new rule-based algorithm for identifying metabolic markers in prostate cancer using tandem mass spectrometry. Bioinformatics 24/24 (2008), 2908-2914. A. Partin a.o.: [Partin tables]. J. Urology 150 (1993), 110-114. A. Partin a.o.: Combination of PSA, clinical stage and Gleason Score to predict pathological stage: A multi-institutional update 1996. J. Urol. April 1997, ... This is an update to the Partin Predictions, based on 4133 men, of which 1384 were assigned to a validation cohort. They report that the prediction for organ confined disease had a 75% sensitivity and a specificity of 57%. The prediction for postiive lymph nodes had a sensitivity of 78% and a specificity of 66%. 15591 Cloud Paweletz/Lance Liotta/Emanuel Petricoin: New technologies for biomarker analysis of prostate cancer progression - laser capture microdissection and tissue proteomics. Urology 57 (suppl. 4 A) April 2001, 160-163. Emanuel Petricoin a.o.: Serum proteomic patterns for detection of prostate cancer. J. NCI 94/20 (2002), 1576-1578. 15579 Sally Pobojewski: A red flag for lethal prostate cancer. Internet October 2002, 4p. 9021 Norbert Pueschel/Gustav Quade/Frederick Far: NCI/PDQ screening of prostate cancer. Internet 1996. Richie a.o.: Effect of patient age on early detection of prostate cancer with serum prostate specific antigen and digital rectal examination. Urology 42 (1993), 365-374. 19844 Robert Serfling/.../Roger Rittmaster: Quantifying the impact of prostate volumes, number of biopsy cores and 5-alpha-reductase inhibitor therapy on the probability of prostate cancer detection using mathematical modeling. J. Urology 177 (2007), 2352-2356. 17181 Swaroop Singh/Desok Kim/James Mohler: Java Web Start based software for automatic quantitative nuclear analysis of prostate cancer and benign prostatic hyperplasia. Biomedical Engineering Online 4/31 (2005). Tom Stamey: Making the most of 6 sextant biopsies. ... (ca. 1997), ... P. Stattin/J. Damber/L. Karlberg/A. Bergh: Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is predictive factor for survival in prostate cancer. J. Urology January 1997, ... S. Takeuchi a.o.: Urinary pyridinoline and deoxypyridinoline as potential markers of bone metastasis in patients with prostate cancer. J. Urology November 1996, ... M. Terris/T. Pham/M. Issa/J. Kabalin: Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J. Urology January 1997, ... 9011 Edward Uthman: The biopsy report. Internet 1994. X. Zhang/L. Jin/H. Sakamoto/I. Tanaka: Immunohistochemical localization of metallothionein in human prostate cancer. J. Urology November 1996, ... 9009 ZZ: AJC/IUAC - TNM staging system for prostate cancer. Internet 1992. 5598 ZZ. Cancer screening gets down to the bone. New Scientist 28 August 1993, 16. An imaging system which detects cancer of the prostate gland may also be able to help doctors to determine whether the prostate cancer has spread to the bone. 8935 ZZ: My biopsy. A patient's story. Internet, ca. 1995. [Archiv] 8949 ZZ: Prostate cancer - screening, diagnosis and management. Internet, ca. 1995. [Archiv] 8948 ZZ: Prognosis of prostate cancer. Internet, ca. 1996. [Archiv] 9299 ZZ: Understanding and using Partin coefficient tables. Internet 1995. 9300 ZZ: Partin coefficient tables: Prediction of lymph node involvement. Internet 1995. 9301 ZZ: Partin coefficient tables: Prediction of probability of organ-confined disease. Internet 1995. 9302 ZZ: Partin coefficient tables: Prediction of seminal vesicle involvement. Internet 1995. 9348 ZZ: Prostate cancer screening and early detection. Internet 1995. 9350 ZZ: The symptoms of prostate cancer. Internet 1995. 9351 ZZ: Sample patient advice and consent form for prostate cancer testing. Internet 1995. 9354 ZZ: PSA, DRE, PAP, RTPCR, TRUS, and other diagnostic acronyms. Internet 1995. 9359 ZZ: The characteristics of a screening test. Internet 1995. 9238 ZZ: Partin coefficient tables: Prediction of probability of established capsular penetration. Internet 1995. 9360 ZZ: To screen or not to screen. Internet 1996. 9349 ZZ: Prostate screening methods. Internet, ca. 1996. 9120 ZZ: Detection and diagnosis of prostate cancer. Internet, ca. 1996. ZZ: Plasma chromogranin a in prostatic carcinoma and neuroendocrine tumors. J. Urology February 1996, 565-... "Conclusions: Chromogranin A [CGA to us PPML'ers] is an excellent marker for neuroendocrine tumors, particularly nonfunctioning tumors, and measurement of chromogranin A is also useful to detect prostatic carcinoma in patients whose PSA is not elevated." 9363 ZZ: NCI/PDQ To screen or not to screen. Internet 1996. 9315 ZZ: NCI/PDQ Screening for prostate cancer. Internet 1997. 20194 ZZ: Prostate cancer diagnosis aided by 3T MRI. Medinews 24 May 2008, 1p. 20922 ZZ: U.S. cancer screening trial shows no early mortality benefit from annual prostate cancer screening. NIH News 18 March 2009, 4p.